{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T16:42:52Z","timestamp":1790959372513,"version":"4.1.0"},"publisher-location":"Cham","reference-count":57,"publisher":"Springer International Publishing","isbn-type":[{"value":"9783031280115","type":"print"},{"value":"9783031280122","type":"electronic"}],"license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023]]},"DOI":"10.1007\/978-3-031-28012-2_22","type":"book-chapter","created":{"date-parts":[[2023,6,28]],"date-time":"2023-06-28T12:02:41Z","timestamp":1687953761000},"page":"413-426","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Evaluation of Curcumin-Piperine Supplementation in COVID-19 Patients Admitted to the Intensive Care: A Double-Blind, Randomized Controlled Trial"],"prefix":"10.1007","author":[{"given":"Gholamreza","family":"Askari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Bagherniya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahra","family":"Kiani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Babak","family":"Alikiaii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahdiye","family":"Mirjalili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehrnaz","family":"Shojaei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shirin","family":"Hassanizadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahdi","family":"Vajdi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Awat","family":"Feizi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammed","family":"Majeed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amirhossein","family":"Sahebkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,6,29]]},"reference":[{"key":"22_CR1","doi-asserted-by":"publisher","unstructured":"Dourado D, Freire DT, Pereira DT, et al (2021) Will curcumin nanosystems be the next promising antiviral alternatives in COVID-19 treatment trials? Biomed Pharmacother 139111578. https:\/\/doi.org\/10.1016\/j.biopha.2021.111578","DOI":"10.1016\/j.biopha.2021.111578"},{"issue":"10224","key":"22_CR2","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/S0140-6736(20)30251-8","volume":"395","author":"R Lu","year":"2020","unstructured":"Lu R, Zhao X, Li J, et al (2020) Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet 395(10224):565\u2013574","journal-title":"Lancet"},{"key":"22_CR3","doi-asserted-by":"publisher","unstructured":"Shah AS, Wood R, Gribben C, et al (2020) Risk of hospital admission with coronavirus disease 2019 in healthcare workers and their households: nationwide linkage cohort study. BMJ 371. https:\/\/doi.org\/10.1136\/bmj.m3582","DOI":"10.1136\/bmj.m3582"},{"key":"22_CR4","unstructured":"World Health Organization (WHO) WHO coronavirus disease (COVID-19) dashboard. https:\/\/www.who.int\/emergencies\/diseases\/novel-coronavirus-2019. Accessed September 19, 2022"},{"issue":"7","key":"22_CR5","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1038\/s41562-021-01122-8","volume":"5","author":"E Mathieu","year":"2021","unstructured":"Mathieu E, Ritchie H, Ortiz-Ospina E, et al (2021) A global database of COVID-19 vaccinations. Nat Hum Behav 5(7):947\u2013953","journal-title":"Nat Hum Behav"},{"issue":"1","key":"22_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11482-020-09898-z","volume":"16","author":"DT Shek","year":"2021","unstructured":"Shek DT (2021) COVID-19 and quality of life: Twelve reflections. Appl Res Qual Life 16(1):1\u201311","journal-title":"Appl Res Qual Life"},{"key":"22_CR7","doi-asserted-by":"publisher","first-page":"155317","DOI":"10.1016\/j.scitotenv.2022.155317","volume":"834","author":"D Wojcieszy\u0144ska","year":"2022","unstructured":"Wojcieszy\u0144ska D, Guzik H, Guzik U (2022) Non-steroidal anti-inflammatory drugs in the era of the Covid-19 pandemic in the context of the human and the environment. Sci Total Environ; 834:155317. https:\/\/doi.org\/10.1016\/j.scitotenv.2022.155317","journal-title":"Sci Total Environ"},{"key":"22_CR8","doi-asserted-by":"publisher","unstructured":"Vahedian-Azimi A, Abbasifard M, Rahimi-Bashar F, et al (2022) Effectiveness of Curcumin on Outcomes of Hospitalized COVID-19 Patients: A Systematic Review of Clinical Trials. Nutrients 14(2). https:\/\/doi.org\/10.3390\/nu14020256","DOI":"10.3390\/nu14020256"},{"issue":"2","key":"22_CR9","doi-asserted-by":"publisher","first-page":"269","DOI":"10.5578\/tt.20219818","volume":"69","author":"K Cano\u011flu","year":"2021","unstructured":"Cano\u011flu K, \u015eaylan B, \u00c7al\u0131\u015fkan T (2021) COVID-19 and thrombosis: Prophylaxis and management. Tuberk Toraks 69(2):269\u2013278","journal-title":"Tuberk Toraks"},{"issue":"1","key":"22_CR10","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1002\/jmv.26232","volume":"93","author":"B Hu","year":"2021","unstructured":"Hu B, Huang S, Yin L (2021) The cytokine storm and COVID-19. J Med Virol 93(1):250\u2013256","journal-title":"J Med Virol"},{"issue":"2","key":"22_CR11","first-page":"327","volume":"34","author":"P Conti","year":"2020","unstructured":"Conti P, Ronconi G, Caraffa A, et al (2020) Induction of pro-inflammatory cytokines (IL-1 and IL-6) and lung inflammation by Coronavirus-19 (COVI-19 or SARS-CoV-2): anti-inflammatory strategies. J Biol Regul Homeost Agents 34(2):327\u2013331","journal-title":"J Biol Regul Homeost Agents"},{"issue":"1","key":"22_CR12","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s43066-021-00082-y","volume":"11","author":"A Vitiello","year":"2021","unstructured":"Vitiello A, La Porta R, D\u2019Aiuto V, Ferrara F (2021) The risks of liver injury in COVID-19 patients and pharmacological management to reduce or prevent the damage induced. Egypt Liver J 11(1):11. https:\/\/doi.org\/10.1186\/s43066-021-00082-y","journal-title":"Egypt Liver J"},{"issue":"4","key":"22_CR13","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1007\/s12185-020-02930-w","volume":"112","author":"X Yuan","year":"2020","unstructured":"Yuan X, Huang W, Ye B, et al (2020) Changes of hematological and immunological parameters in COVID-19 patients. Int J Hematol 112(4):553\u2013559","journal-title":"Int J Hematol"},{"issue":"2","key":"22_CR14","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.autrev.2017.11.016","volume":"17","author":"AA Momtazi-Borojeni","year":"2018","unstructured":"Momtazi-Borojeni AA, Haftcheshmeh SM, Esmaeili SA, et al (2018) Curcumin: A natural modulator of immune cells in systemic lupus erythematosus. Autoimmun Rev 17(2):125\u2013135","journal-title":"Autoimmun Rev"},{"issue":"5","key":"22_CR15","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1097\/CEJ.0b013e32832c389e","volume":"18","author":"M Iranshahi","year":"2009","unstructured":"Iranshahi M, Sahebkar A, Takasaki M, et al (2009) Cancer chemopreventive activity of the prenylated coumarin, umbelliprenin, in vivo. Eur J Cancer Prev 18(5):412\u2013415","journal-title":"Eur J Cancer Prev"},{"issue":"11","key":"22_CR16","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1055\/s-0034-1389986","volume":"65","author":"Y Panahi","year":"2014","unstructured":"Panahi Y, Ghanei M, Bashiri S, et al (2014) Short-term Curcuminoid Supplementation for Chronic Pulmonary Complications due to Sulfur Mustard Intoxication: Positive Results of a Randomized Double-blind Placebo-controlled Trial. Drug Res 65(11):567\u2013573","journal-title":"Drug Res"},{"key":"22_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ctim.2017.05.006","volume":"33","author":"Y Panahi","year":"2017","unstructured":"Panahi Y, Khalili N, Sahebi E, et al (2017) Curcuminoids modify lipid profile in type 2 diabetes mellitus: A randomized controlled trial. Complement Ther Med 33:1\u20135","journal-title":"Complement Ther Med"},{"key":"22_CR18","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.phrs.2018.09.012","volume":"136","author":"N Parsamanesh","year":"2018","unstructured":"Parsamanesh N, Moossavi M, Bahrami A, et al (2018) Therapeutic potential of curcumin in diabetic complications. Pharmacol Res 136:181\u2013193","journal-title":"Pharmacol Res"},{"issue":"29","key":"22_CR19","doi-asserted-by":"publisher","first-page":"43732","DOI":"10.1007\/s11356-022-20137-w","volume":"29","author":"M Shah","year":"2022","unstructured":"Shah M, Murad W, Mubin S, et al (2022) Multiple health benefits of curcumin and its therapeutic potential. Environ Sci Pollut Res Int 29(29):43732\u201343744","journal-title":"Environ Sci Pollut Res Int"},{"issue":"22","key":"22_CR20","doi-asserted-by":"publisher","first-page":"4029","DOI":"10.3390\/molecules24224029","volume":"24","author":"AM Gorabi","year":"2019","unstructured":"Gorabi AM, Kiaie N, Hajighasemi S, et al (2019) The effect of curcumin on the differentiation of mesenchymal stem cells into mesodermal lineage. Molecules 24(22):4029. https:\/\/doi.org\/10.3390\/molecules24224029","journal-title":"Molecules"},{"key":"22_CR21","doi-asserted-by":"publisher","first-page":"104765","DOI":"10.1016\/j.phrs.2020.104765","volume":"156","author":"M Mohajeri","year":"2020","unstructured":"Mohajeri M, Bianconi V, \u00c1vila-Rodriguez MF, et al (2020) Curcumin: a phytochemical modulator of estrogens and androgens in tumors of the reproductive system. Pharmacol Res 156:104765. https:\/\/doi.org\/10.1016\/j.phrs.2020.104765","journal-title":"Pharmacol Res"},{"issue":"11","key":"22_CR22","doi-asserted-by":"publisher","first-page":"6417","DOI":"10.1002\/ptr.7294","volume":"35","author":"M Hassaniazad","year":"2021","unstructured":"Hassaniazad M, Eftekhar E, Inchehsablagh BR, et al (2021) A triple-blind, placebo-controlled, randomized clinical trial to evaluate the effect of curcumin-containing nanomicelles on cellular immune responses subtypes and clinical outcome in COVID-19 patients. Phytother Res 35(11):6417\u20136427","journal-title":"Phytother Res"},{"key":"22_CR23","doi-asserted-by":"publisher","first-page":"119201","DOI":"10.1016\/j.lfs.2021.119201","volume":"284","author":"AB Kunnumakkara","year":"2021","unstructured":"Kunnumakkara AB, Rana V, Parama D, et al (2021) COVID-19, cytokines, inflammation, and spices: How are they related? Life Sci 284:119201. https:\/\/doi.org\/10.1016\/j.lfs.2021.119201","journal-title":"Life Sci"},{"key":"22_CR24","doi-asserted-by":"publisher","first-page":"4503","DOI":"10.2147\/DDDT.S327378","volume":"15","author":"Y Peng","year":"2021","unstructured":"Peng Y, Ao M, Dong B, et al (2021) Anti-Inflammatory Effects of Curcumin in the Inflammatory Diseases: Status, Limitations and Countermeasures. Drug Des Devel Ther 15:4503\u20134525","journal-title":"Drug Des Devel Ther"},{"issue":"11","key":"22_CR25","doi-asserted-by":"publisher","first-page":"2911","DOI":"10.1002\/ptr.6738","volume":"34","author":"F Zahedipour","year":"2020","unstructured":"Zahedipour F, Hosseini SA, Sathyapalan T, et al (2020) Potential effects of curcumin in the treatment of COVID-19 infection. Phytother Res 34(11):2911\u20132920","journal-title":"Phytother Res"},{"issue":"4","key":"22_CR26","doi-asserted-by":"publisher","first-page":"1442","DOI":"10.1002\/ptr.7350","volume":"36","author":"Z Heidari","year":"2022","unstructured":"Heidari Z, Daei M, Boozari M, et al (2022) Curcumin supplementation in pediatric patients: A systematic review of current clinical evidence. Phytother Res 36(4):1442\u20131458","journal-title":"Phytother Res"},{"issue":"4","key":"22_CR27","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1016\/j.bcp.2007.08.016","volume":"75","author":"A Goel","year":"2008","unstructured":"Goel A, Kunnumakkara AB, Aggarwal BB (2008)Curcumin as \"Curecumin\": from kitchen to clinic. Biochem Pharmacol 75(4):787\u2013809","journal-title":"Biochem Pharmacol"},{"issue":"6","key":"22_CR28","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1021\/np400148e","volume":"76","author":"A Minassi","year":"2013","unstructured":"Minassi A, S\u00e1nchez-Duffhues G, Collado JA, et al (2013) Dissecting the pharmacophore of curcumin. Which structural element is critical for which action? J Nat Prod 76(6):1105\u20131112","journal-title":"J Nat Prod"},{"issue":"4","key":"22_CR29","doi-asserted-by":"publisher","first-page":"211","DOI":"10.15171\/jhp.2018.33","volume":"7","author":"N Boroumand","year":"2018","unstructured":"Boroumand N, Samarghandian S, Hashemy SI (2018) Immunomodulatory, anti-inflammatory, and antioxidant effects of curcumin. J Herbmed Pharmacol 7(4):211\u2013219","journal-title":"J Herbmed Pharmacol"},{"issue":"1","key":"22_CR30","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1186\/s13063-022-06375-w","volume":"23","author":"G Askari","year":"2022","unstructured":"Askari G, Sahebkar A, Soleimani D, et al (2022) The efficacy of curcumin-piperine co-supplementation on clinical symptoms, duration, severity, and inflammatory factors in COVID-19 outpatients: a randomized double-blind, placebo-controlled trial. Trials 23(1):472. https:\/\/doi.org\/10.1186\/s13063-022-06375-w","journal-title":"Trials"},{"key":"22_CR31","doi-asserted-by":"publisher","first-page":"104921","DOI":"10.1016\/j.phrs.2020.104921","volume":"159","author":"S Hassanzadeh","year":"2020","unstructured":"Hassanzadeh S, Read MI, Bland AR, et al (2020) Curcumin: an inflammasome silencer. Pharmacol Res 159:104921. https:\/\/doi.org\/10.1016\/j.phrs.2020.104921","journal-title":"Pharmacol Res"},{"issue":"5","key":"22_CR32","doi-asserted-by":"publisher","first-page":"5728","DOI":"10.1002\/jcp.27442","volume":"234","author":"B Farhood","year":"2019","unstructured":"Farhood B, Mortezaee K, Goradel NH, et al (2019) Curcumin as an anti-inflammatory agent: Implications to radiotherapy and chemotherapy. J Cell Physiol 234(5):5728\u20135740","journal-title":"J Cell Physiol"},{"key":"22_CR33","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.brainres.2012.10.002","volume":"1488","author":"P Rinwa","year":"2012","unstructured":"Rinwa P, Kumar A (2012) Piperine potentiates the protective effects of curcumin against chronic unpredictable stress-induced cognitive impairment and oxidative damage in mice. Brain Res 1488:38\u201350","journal-title":"Brain Res"},{"issue":"1","key":"22_CR34","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.ijpharm.2015.05.008","volume":"490","author":"Q Li","year":"2015","unstructured":"Li Q, Zhai W, Jiang Q, et al (2015) Curcumin\u2013piperine mixtures in self-microemulsifying drug delivery system for ulcerative colitis therapy. International Journal of Pharmaceutics 490(1):22\u201331","journal-title":"International Journal of Pharmaceutics"},{"issue":"1","key":"22_CR35","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1186\/s13063-021-05372-9","volume":"22","author":"G Askari","year":"2021","unstructured":"Askari G, Alikiaii B, Soleimani D, et al (2021) Effect of curcumin-pipeine supplementation on clinical status, mortality rate, oxidative stress, and inflammatory markers in critically ill ICU patients with COVID-19: a structured summary of a study protocol for a randomized controlled trial. Trials 22(1):434. https:\/\/doi.org\/10.1186\/s13063-021-05372-9","journal-title":"Trials"},{"issue":"2","key":"22_CR36","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1002\/ptr.7374","volume":"36","author":"E Honarkar Shafie","year":"2022","unstructured":"Honarkar Shafie E, Taheri F, Alijani N, et al (2022) Effect of nanocurcumin supplementation on the severity of symptoms and length of hospital stay in patients with COVID-19: A randomizd double-blind placebo-controlled trial. Phytother Res 36(2):1013\u20131022","journal-title":"Phytother Res"},{"key":"22_CR37","doi-asserted-by":"publisher","first-page":"669362","DOI":"10.3389\/fphar.2021.669362","volume":"12","author":"KS Pawar","year":"2021","unstructured":"Pawar KS, Mastud RN, Pawar SK, et al (2021) Oral Curcumin With Piperine as Adjuvant Therapy for the Treatment of COVID-19: A Randomized Clinical Trial. Front Pharmacol 12:669362. https:\/\/doi.org\/10.3389\/fphar.2021.669362","journal-title":"Front Pharmacol"},{"issue":"8","key":"22_CR38","doi-asserted-by":"publisher","first-page":"4068","DOI":"10.1002\/fsn3.2226","volume":"9","author":"R Ahmadi","year":"2021","unstructured":"Ahmadi R, Salari S, Sharifi MD, et al (2021) Oral nano-curcumin formulation efficacy in the management of mild to moderate outpatient COVID-19: A randomized triple-blind placebo-controlled clinical trial. Food Sci Nutr 9(8):4068\u20134075","journal-title":"Food Sci Nutr"},{"issue":"2","key":"22_CR39","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1002\/ptr.7375","volume":"36","author":"A Asadirad","year":"2022","unstructured":"Asadirad A, Nashibi R, Khodadadi A, et al (2022) Antiinflammatory potential of nano-curcumin as an alternative therapeutic agent for the treatment of mild-to-moderate hospitalized COVID-19 patients in a placebo-controlled clinical trial. Phytother Res 36(2):1023\u20131031","journal-title":"Phytother Res"},{"issue":"Pt B","key":"22_CR40","doi-asserted-by":"publisher","first-page":"107088","DOI":"10.1016\/j.intimp.2020.107088","volume":"89","author":"H Valizadeh","year":"2020","unstructured":"Valizadeh H, Abdolmohammadi-Vahid S, Danshina S et al (2020) Nano-curcumin therapy, a promising method in modulating inflammatory cytokines in COVID-19 patients. Int Immunopharmacol 89(Pt B):107088. https:\/\/doi.org\/10.1016\/j.intimp.2020.107088","journal-title":"Int Immunopharmacol"},{"issue":"2","key":"22_CR41","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1002\/hep.31301","volume":"72","author":"F Lei","year":"2020","unstructured":"Lei F, Liu YM, Zhou F, et al (2020) Longitudinal Association Between Markers of Liver Injury and Mortality in COVID-19 in China. Hepatology 72(2):389\u2013398","journal-title":"Hepatology"},{"issue":"7","key":"22_CR42","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1097\/MEG.0000000000001817","volume":"33","author":"K Wijarnpreecha","year":"2021","unstructured":"Wijarnpreecha K, Ungprasert P, Panjawatanan P, et al (2021) COVID-19 and liver injury: a meta-analysis. Eur J Gastroenterol Hepatol 33(7):990\u2013995","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"22_CR43","doi-asserted-by":"publisher","DOI":"10.1017\/s0950268820002186","volume":"148","author":"LZ Chen","year":"2020","unstructured":"Chen LZ, Lin ZH, Chen J, et al (2020) Can elevated concentrations of ALT and AST predict the risk of \u2019recurrence\u2019 of COVID-19? Epidemiol Infect 148:e218 https:\/\/doi.org\/10.1017\/s0950268820002186","journal-title":"Epidemiol Infect"},{"key":"22_CR44","doi-asserted-by":"publisher","first-page":"102283","DOI":"10.1016\/j.ctim.2019.102283","volume":"48","author":"M Jalali","year":"2020","unstructured":"Jalali M, Mahmoodi M, Mosallanezhad Z, et al (2020) The effects of curcumin supplementation on liver function, metabolic profile and body composition in patients with non-alcoholic fatty liver disease: A systematic review and meta-analysis of randomized controlled trials. Complement Ther Med 48:102283. https:\/\/doi.org\/10.1016\/j.ctim.2019.102283","journal-title":"Complement Ther Med"},{"issue":"1","key":"22_CR45","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.imr.2018.07.004","volume":"8","author":"F Mansour-Ghanaei","year":"2019","unstructured":"Mansour-Ghanaei F, Pourmasoumi M, Hadi A, Joukar F (2019) Efficacy of curcumin\/turmeric on liver enzymes in patients with non-alcoholic fatty liver disease: A systematic review of randomized controlled trials. Integr Med Res 8(1):57\u201361","journal-title":"Integr Med Res"},{"issue":"11","key":"22_CR46","doi-asserted-by":"publisher","first-page":"2161","DOI":"10.1002\/tox.23330","volume":"36","author":"G Xu","year":"2021","unstructured":"Xu G, Gu Y, Yan N, et al (2021) Curcumin functions as an anti-inflammatory and antioxidant agent on arsenic-induced hepatic and kidney injury by inhibiting MAPKs\/NF-\u03baB and activating Nrf2 pathways. Environ Toxicol 36(11):2161\u20132173","journal-title":"Environ Toxicol"},{"key":"22_CR47","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1016\/j.biopha.2016.06.036","volume":"83","author":"W Zhong","year":"2016","unstructured":"Zhong W, Qian K, Xiong J, et al (2016) Curcumin alleviates lipopolysaccharide induced sepsis and liver failure by suppression of oxidative stress-related inflammation via PI3K\/AKT and NF-\u03baB related signaling. Biomed Pharmacother 83:302\u2013313","journal-title":"Biomed Pharmacother"},{"issue":"19","key":"22_CR48","doi-asserted-by":"publisher","first-page":"4980","DOI":"10.12998\/wjcc.v9.i19.4980","volume":"9","author":"F Zhou","year":"2021","unstructured":"Zhou F, Xia J, Yuan HX, et al (2021) Liver injury in COVID-19: Known and unknown. World J Clin Cases 9(19):4980\u20134989","journal-title":"World J Clin Cases"},{"issue":"Suppl 2","key":"22_CR49","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1590\/1806-9282.66.s2.112","volume":"66Suppl 2","author":"S\u00c1R Nogueira","year":"2020","unstructured":"Nogueira S\u00c1 R, Oliveira SCS, Carvalho AFM, et al (2020) Renal changes and acute kidney injury in covid-19: a systematic review. Rev Assoc Med Bras (1992) 66Suppl 2(Suppl 2):112\u2013117","journal-title":"Rev Assoc Med Bras (1992)"},{"key":"22_CR50","doi-asserted-by":"publisher","first-page":"3029","DOI":"10.2147\/IDR.S321915","volume":"14","author":"J Qu","year":"2021","unstructured":"Qu J, Zhu HH, Huang XJ, et al (2021) Abnormal Indexes of Liver and Kidney Injury Markers Predict Severity in COVID-19 Patients. Infect Drug Resist 14:3029\u20133040","journal-title":"Infect Drug Resist"},{"key":"22_CR51","doi-asserted-by":"publisher","first-page":"101606","DOI":"10.1016\/j.tmaid.2020.101606","volume":"36","author":"Y Huang","year":"2020","unstructured":"Huang Y, Tu M, Wang S, et al (2020) Clinical characteristics of laboratory confirmed positive cases of SARS-CoV-2 infection in Wuhan, China: A retrospective single center analysis. Travel Med Infect Dis 36:101606. https:\/\/doi.org\/10.1016\/j.tmaid.2020.101606","journal-title":"Travel Med Infect Dis"},{"issue":"7","key":"22_CR52","doi-asserted-by":"publisher","first-page":"300060521103012","DOI":"10.1177\/03000605211030124","volume":"49","author":"SH Fouad","year":"2021","unstructured":"Fouad SH, Allam MF, Taha SI, et al (2021) Comparison of hemoglobin level and neutrophil to lymphocyte ratio as prognostic markers in patients with COVID-19. J Int Med Res 49(7):3000605211030124. https:\/\/doi.org\/10.1177\/03000605211030124","journal-title":"J Int Med Res"},{"issue":"8","key":"22_CR53","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1007\/s10654-020-00678-5","volume":"35","author":"PE Taneri","year":"2020","unstructured":"Taneri PE, G\u00f3mez-Ochoa SA, et al (2020) Anemia and iron metabolism in COVID-19: a systematic review and meta-analysis. Eur J Epidemiol 35(8):763\u2013773","journal-title":"Eur J Epidemiol"},{"key":"22_CR54","unstructured":"Simple Plex\u2122; Bio-Techne; Minneapolis, MN, USA. https:\/\/www.bio-techne.com\/instruments\/simple-plex"},{"key":"22_CR55","unstructured":"Cytokine Array \u2013 Human Cytokine Antibody Array (Membrane, 42 Targets) (ab133997); Abcam; Cambridge, United Kingdom. https:\/\/www.abcam.com\/cytokine-array%2D%2Dhuman-cytokine-antibody-array-membrane-42-targets-ab133997.html"},{"key":"22_CR56","unstructured":"LEGENDplexTM Human Inflammation Panel 1 multiplex immunoassay. BioVendor; Brno, Czechia. https:\/\/www.biolegend.com\/nl-be\/products\/legendplex-human-inflammation-panel-1-13-plex-with-v-bottom-plate-16929"},{"key":"22_CR57","unstructured":"Multiplex Cytokine Assays with Luminex; Redwood City, CA, USA. https:\/\/www.precisionformedicine.com\/specialty-lab-services\/cytokine-analysis\/luminex\/"}],"container-title":["Advances in Experimental Medicine and Biology","Application of Omic Techniques to Identify New Biomarkers and Drug Targets for COVID-19"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-031-28012-2_22","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,28]],"date-time":"2023-06-28T12:06:12Z","timestamp":1687953972000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-3-031-28012-2_22"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023]]},"ISBN":["9783031280115","9783031280122"],"references-count":57,"URL":"https:\/\/doi.org\/10.1007\/978-3-031-28012-2_22","relation":{},"ISSN":["0065-2598","2214-8019"],"issn-type":[{"value":"0065-2598","type":"print"},{"value":"2214-8019","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023]]},"assertion":[{"value":"29 June 2023","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}